Cancer industry fraud Laetrile at Sloan Kettering’

"Our current medical system has been
masterfully orchestrated by the drug
companies to create a system that gives
the perception of science-based medicine
when it is really a heavily manipulated
process designed to boost their profits,
and more accurately labeled science-biased
medicine." Dr Joseph Mercola

This film is about the story of the
40-year Laetrile cover-up, which
is being made available for free
viewing by the producers through
October 24th.

The film was directed by Eric Merola,
who directed the two brilliant films
about the intrepid Dr. Stanislaw
Burzynski, who discovered a cure for
some cancers and has spent decades
fighting the Federal government and
the State government if Texas, who
have legally besieged him over his
medical breakthroughs for decades,
without success.

‘Second Opinion’ is about the work of
Dr. Kanematsu Sugiura, who spent
most of his career at Memorial Sloan
Kettering Cancer Center and one of
the top cancer researchers of the
1970s.

Dr. Sugiura discovered that Laetrile,
derived from apricot pits, had very
positive effects in preventing the spread
of malignant lung tumors in laboratory
mice.

In control groups, which received only
plain saline, the lung tumors spread in
80 to 90 percent of the animals. But in
those given Laetrile, the tumors spread
in only 10 to 20 percent…

Soon after these findings, a cover-up
began, causing a Sloan-Kettering Public
Relations official, Ralph Moss to follow
his conscience and hold a press
conference about the active suppression
of Dr. Sugiura’s studies, costing him his
job, naturally.

According to Moss: "The individuals on
Sloan Kettering’s Board of Directors were
a ‘Who’s Who’ of investors in petrochemical
and other polluting industries. In other
words, the hospital was being run by people
who made their wealth by investing in the
worst cancer-causing things on the planet."

Quoting from Dr. Joseph Mercola, whose
site, Mercola.com is hosting this film (and

selling my company’s DVD, ‘The Grounded 2’):

"The Board was dominated by CEOs from
top pharmaceutical companies that produce
cancer drugs, whose interest was in
promoting chemotherapy and undermining
natural therapies. For example, both the
Chairman and Vice President of Bristol-Myers
Squibb (the world’s leading manufacturer of
chemotherapy drugs) occupied high positions
on the Board. Of the nine members of the
hospital’s powerful Institutional Policy
Committee, seven had ties to the
pharmaceutical industry. Even the hospital
itself invested in stock of these drug
companies. The Board also included
directors of the biggest tobacco companies
in the US – Phillip Morris and RJR Nabisco.

Moss writes:

"If a cure for cancer were to be found in an
extract from the lowly apricot seed, it would
be a terrible economic blow to the cancer-
drug industry," and as William W. Vodra, the
former Associate Chief Counsel for Drugs at
the FDA said: "Nobody is going to pay
$70,000 for a new cancer drug if they can
buy Laetrile for 75 cents."

It is plain that Sloan Kettering’s Board
realized that Laetrile offered no hope, as a
profitable cancer treatment – so it was
squashed. Although new studies continue
to support Dr. Sugiura’s findings, they
have yet to issue an apology to him and
the millions of people who have lost loved
ones to lung cancer (including me) but you
can ask them to do so, by signing here.

As Dr. Mercola says, the cancer industry
"is based on toxic drugs, dangerous
surgeries, and expensive machines. There’s
an enormous amount of money to be made
in this system, and those who threaten to
overturn it will pay a steep price…

"We continue to see one case after another
of shocking medical science fraud, particularly
in the extremely profitable cancer industry.